DIVISLAB's weekly performance was disappointing, with a return of -0.93% and a Sharpe Ratio of -0.23, indicating poor risk-adjusted returns. The stock's volatility was high at 21.39%, making it a risky investment this week. Compared to its peers, DIVISLAB underperformed DRREDDY but outperformed SUNPHARMA and CIPLA. Overall, the stock's high volatility and negative returns make it a cautionary investment.

[Volatility: 21.39%]